Diabetes Research on Patient Stratification
NCT03814915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3049
Last updated 2020-01-18
Summary
The overarching goal of the IMI DIRECT (Innovative Medicines Initiative Diabetes Research on Patient Stratification) Consortium is the identification of biomarkers that aid therapeutic targeting in prediabetes (Study 1) or early onset type 2 diabetes (Study 2).
Conditions
- Type2 Diabetes
Sponsors & Collaborators
-
Lund University
lead OTHER
Principal Investigators
-
Ewan Pearson, FRCP · University of Dundee
-
Paul W Franks, PhD · Lund University
Eligibility
- Min Age
- 35 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-15
- Primary Completion
- 2019-07-31
- Completion
- 2019-07-31
More Related Trials
-
Time-In-Range Based Risk Stratification of Type 2 Diabetes Microvascular Complications
NCT05787990 ·Status: UNKNOWN
-
Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes
NCT00143013 ·Status: UNKNOWN
-
Uncovering the 'ORIGINS' of Diabetes
NCT02226640 ·Status: COMPLETED
-
Efficacy Study of the DIAMOND System to Treat Type 2 Diabetes Mellitus
NCT01529216 ·Status: COMPLETED ·Phase: NA
-
Characterization of Type 2 Diabetes Subgroups at Diagnosis: a Necessary Step Towards Precision Medicine in Diabetes.
NCT05333718 ·Status: RECRUITING
-
Mechanisms of Endothelial Dysfunction in Type 2 Diabetes
NCT02311075 ·Status: COMPLETED ·Phase: NA
-
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
NCT07198191 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes
NCT00318032 ·Status: UNKNOWN ·Phase: NA
-
Development, Implementation and Evaluation of a Complex Regional Intervention for Type 2 Diabetes: Diabetes Project Aalst
NCT00824499 ·Status: UNKNOWN ·Phase: NA
-
Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related Complications
NCT07250607 ·Status: ACTIVE_NOT_RECRUITING
-
Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes
NCT02687152 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
NCT05046483 ·Status: RECRUITING
-
Precision Medicine for Preventing Type 2 Diabetes: a Step Forward
NCT05147961 ·Status: RECRUITING ·Phase: NA
-
The Early Predictors for Developing Type 2 Diabetes Mellitus in Patients With Chronic Obstructive Pulmonary Disease
NCT03152994 ·Status: COMPLETED
-
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
NCT03824002 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM)
NCT00814190 ·Status: COMPLETED ·Phase: NA
-
Arginase Inhibition in Type 1 and Type 2 Diabetes Mellitus
NCT05806502 ·Status: COMPLETED ·Phase: NA
-
The DIAMOND® for the Treatment of Type 2 Diabetes
NCT02079376 ·Status: UNKNOWN ·Phase: NA
-
Arterial Stiffness and Complication Risk in Type 2 Diabetes
NCT02001532 ·Status: COMPLETED
-
Role of SGLT2I in Patients With Myocardial Infarction
NCT06245980 ·Status: UNKNOWN
-
DIABASE; Diabetes Mellitus Registry in Second Care
NCT05584293 ·Status: RECRUITING
-
Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China
NCT03064841 ·Status: COMPLETED
-
AI Ready and Exploratory Atlas for Diabetes Insights
NCT06002048 ·Status: ENROLLING_BY_INVITATION
-
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
NCT01105858 ·Status: SUSPENDED
-
New IR Biomarkers (Myokines) in Colombian People
NCT03244449 ·Status: COMPLETED